May 16, 2013 (Newswise) —  A clinical trial at the University of Chicago Medicine aims to find new ways of preventing type 2 diabetes or slow its progression by treating participants with medications normally used for people who have had full-blown diabetes for at least one year. The trial will enroll individuals who are pr

Continue reading "Clinical Trial Aims to Prevent Type 2 Diabetes Through Medication"

December 10, 2012 (The Endocrine Society) — Metformin therapy has a beneficial treatment effect over placebo in improving body mass index (BMI) and fasting glucose levels in obese children, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The study showed reduction in BMI was sustained for six months.

Childhood obesity has increased globally over the last two decades and it is link

Continue reading "Metformin Improves Blood Glucose Levels and BMI in Very Obese Children"

December 10, 2012 (Newswise) — A medication being tested to help smokers kick the habit also may help avoid the weight gain that is common after quitting but only in women, according to a study published in the December issue of Biological Psychiatry. This is the first medication shown to reduce weight gain for up to one year in women smokers who quit.

Naltrexone — an opioi

Continue reading "Drug Helps Women Who Stop Smoking Keep Off Weight"

December 23, 2012 (Newswise) — Insulin resistance, or prediabetes, in individuals with kidney disease may be caused by the progressive retention of certain compounds that are normally excreted by the kidneys in healthy individuals, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings might be used to prevent i

Continue reading "New Target for Treating Prediabetes in Patients with Kidney Disease"

January 7, 2013 (Perelman School of Medicine) — A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, found that the diabetes drug metformin works in a different way than previously understood. Their research in mice found that metformin suppresses the liver hormone glucagon's

Continue reading "Most-Used Diabetes Drug Works in Different Way than Previously Thought"